PharmaEssentia Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15,635	9,735	5,106	2,882	656.51
Revenue Growth (YoY)	60.61%	90.67%	77.15%	339.00%	17.81%
Cost of Revenue	1,684	1,177	610.54	812.29	378.86
Gross Profit	13,950	8,558	4,495	2,070	277.65
Selling, General & Admin	5,554	4,234	4,184	2,672	1,827
Research & Development	3,468	2,588	2,224	1,426	1,273
Operating Expenses	9,022	6,822	6,408	4,098	3,100
Operating Income	4,928	1,736	-1,913	-2,028	-2,822
Interest Expense	-25.53	-22.19	-46.69	-18.53	-9.97
Interest & Investment Income	642.52	924.06	585.13	40.44	4.63
Earnings From Equity Investments	-4.46	-	-	-	-
Currency Exchange Gain (Loss)	-	376.38	375.7	122.36	-1.85
Other Non Operating Income (Expenses)	-557.83	-18.74	12.33	42.15	4.09
EBT Excluding Unusual Items	4,983	2,996	-986.93	-1,842	-2,826
Gain (Loss) on Sale of Assets	-	-0.93	-	-0.1	-0.07
Other Unusual Items	-	-	-	-	14.59
Pretax Income	4,983	2,995	-986.93	-1,842	-2,811
Income Tax Expense	-62.23	29.15	-363.1	-467.06	-
Net Income	5,045	2,966	-623.84	-1,375	-2,811
Net Income to Common	5,045	2,966	-623.84	-1,375	-2,811
Net Income Growth	70.13%	-	-	-	-
Shares Outstanding (Basic)	370	367	358	315	289
Shares Outstanding (Diluted)	371	371	358	315	289
Shares Change (YoY)	0.14%	3.59%	13.47%	9.24%	7.39%
EPS (Basic)	13.64	8.07	-1.74	-4.36	-9.74
EPS (Diluted)	13.59	8.00	-1.74	-4.36	-9.74
EPS Growth	69.84%	-	-	-	-
Free Cash Flow	3,366	1,685	-1,996	-1,818	-2,532
Free Cash Flow Per Share	9.07	4.54	-5.58	-5.76	-8.77
Dividend Per Share	-	0.990	-	-	-
Gross Margin	89.23%	87.91%	88.04%	71.82%	42.29%
Operating Margin	31.52%	17.83%	-37.48%	-70.37%	-429.91%
Profit Margin	32.27%	30.46%	-12.22%	-47.70%	-428.17%
Free Cash Flow Margin	21.53%	17.31%	-39.09%	-63.06%	-385.74%
EBITDA	5,327	1,847	-1,824	-1,912	-2,703
EBITDA Margin	34.07%	18.97%	-35.73%	-66.34%	-
D&A For EBITDA	398.6	110.52	89.24	116.28	119.59
EBIT	4,928	1,736	-1,913	-2,028	-2,822
EBIT Margin	31.52%	17.83%	-37.48%	-70.37%	-
Effective Tax Rate	-	0.97%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.